Table 4.
Mean survival time according to demographic and clinicopathologic factors, log-rank test
| Mean survival time±SE | p | |
|---|---|---|
| Gender | 0.88 | |
| Female | 79.37±10.70 | |
| Male | 64.84±6.09 | |
| Obesity | 0.58 | |
| No | 67.25±5.61 | |
| Yes | 71.64±13.19 | |
| Tumor location | 0.73 | |
| Antrum | 78.61±7.75 | |
| Corpus | 67.78±12.38 | |
| Cardia | 46.14±8.27 | |
| Gastrectomy | 0.42 | |
| Total | 57.70±10.72 | |
| Distal | 79.74±7.61 | |
| Lymph node metastasis | 0.09 | |
| Yes | 62.36±10.56 | |
| No | 71.99±5.57 | |
| Stage | 0.17 | |
| 1a | 72.36±6.76 | |
| 1b | 70.28±9.05 | |
| Grade | 0.36 | |
| High | 81.74±8.63 | |
| Low | 61.95±7.44 | |
| Lymphovascular invasion | 0.07 | |
| Yes | 58.18±14.63 | |
| No | 69.38±5.17 | |
| Perineural invasion | 0.30 | |
| Yes | 26.5±15.20 | |
| No | 78.44±6.74 | |
| NLR | 0.003 | |
| High | 41.46±5.51 | |
| Low | 92.17±7.19 |
NLR: Neutrophil-to-lymphocyte ratio.